New therapeutic strategy for chemotherapy resistance in ovarian cancer

(The Wistar Institute) A Wistar study demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment.
Source: EurekAlert! - Biology - Category: Biology Source Type: news